The relationship between the healthcare professional and the pharmaceutical industry is based on an exchange of information and this is what the IDF Congress is all about.
We believe in the value of face-to-face education and personal exchange. This will again be showcased at the IDF Congress 2019 in Busan, Korea - 2- 6 December 2019 - which will provide opportunities for peer-to-peer interactions with representatives from all sectors of the global diabetes community.
Whether you joined us at past IDF Congresses or consider participating for the first time, we firmly believe that the IDF Congress 2019 in Busan will be beneficial for both you and our delegates.
The IDF Congress has become one of the largest international medical events in diabetes, bringing together thousands of healthcare professionals, hundreds of world-renowned speakers, more than 50 national and international exhibitors and representatives from IDF’s member network in over 160 countries.
The IDF 2019 programme will feature up to ten parallel sessions spread over various streams, tackling all aspects of diabetes, from Basic and Clinical Science to Education and Public Health to Advocacy and Living with diabetes. The IDF congress also provides young researchers with exposure to an international professional audience, allowing them to become multipliers in their region and daily practice.
A virtual walkwill familiarize yourself with BEXCO, the IDF 2019 venue. The IDF Congress will stretch across the Auditorium, the Convention Hall and Exhibition Center I. All relevant statistics to help you better understand the IDF 2019 audience and programme is available in our congress library.
We look forward to welcoming you to the IDF Congress 2019 in Busan, Korea. For additional information and queries, please contact:
American Association of Clinical Endocrinologists (AACE) Acon Laboratories Alere Ascensia AstraZeneca Bayer Becton Dickinson Boehringer Ingelheim Cambridge Weight Plan Cipla Dasman Diabetes Institute Diabetes India Diabetik Foot Care India European Association for the Study of Diabetes Evia Medical Technologies Exevia Fred Hollows Gabric Glenmark Hikma Pharmaceuticals Imperial College London Diabetes Centre Inbody Insulin For Life International Society for Pediatric and Adolescent Diabetes ISPAD Julphar LG Chem Lilly Diabetes MedGenome Merck MSD NeoBiocon Neopharma Novartis Novo Nordisk Optomed Owen Mumford Pic Solutions/Artsana Plos Roche Diabetes Care Sanofi Servier International Sunstar Suisse SA Takeda The Diabetes Centre The Searle Company Tonghua Dongbao Pharmaceutical Trividia Health World Diabetes Foundation World Union of Wound Healing Societies